Kidney Function Test Market Size is valued at USD 863.35 Mn in 2022 and is predicted to reach USD 1,458.50 Mn by the year 2031 at a 6.08% CAGR during the forecast period for 2023-2031.
The kidneys are essential organs that filter blood and remove waste products and excess fluids from the body, so tests that measure kidney function are in high demand. These tests can aid in diagnosing conditions like chronic kidney disease, acute kidney injury, kidney stones, and urinary tract infections (UTIs). The market is likely to expand because the growth in the test market is expected to be greatly boosted during the anticipated period as a result of increasing access to at-home kidney function testing and theorizing R&D initiatives for the general expansion of fresh goods.
Increases in chronic renal illness, the need for more accurate kidney function testing, quick diagnostic improvements, and other factors are driving the industry forward. Furthermore, major contributors to the worldwide increase in chronic renal disease are diabetes and higher blood pressure. The market is expected to slow down during the projection period as a result of rising diabetes rates.
However, the market growth is hampered in the long run, and the global demand for these renal medications may slow the market's expansion. Loss of appetite, fever, and rashes are just a few side effects that could slow down the market. Changes in blood tests may also indicate liver and kidney problems, as well as an uncommon but serious side effect of a drop in blood cell levels. Therefore, market obstacles are caused by these reasons.
The COVID-19 pandemic exerted a profound and extensive influence on the healthcare system. Patients with COVID-19 typically exhibit abnormalities in their kidneys, including elevated levels of protein or blood in their urine. Adults with COVID-19 have been found to suffer from acute renal damage and subsequent loss of kidney function.
The Kidney Function Test Market is segmented based on Product, Type And End-User. The Product segment consists of dipsticks, reagents, and disposables. By type, the market is divided into urine tests and blood tests, in which urine tests include Urine Protein, Microalbumin, and creatinine Clearance. At the same time, Blood Test consists of Serum Creatinine Tests, Glomerular Filtration Rate Tests, and Blood Urea Nitrogen Tests. Lastly, By End-User, the market is divided into Hospitals, Diagnostics Laboratories, Research Laboratories and Institutes.
The dipstick segment is projected to grow rapidly in the global kidney function test market. Dipsticks is expected to hold a major global market share in 2022. Dipsticks are useful for diagnosing various kidney and urinary tract issues, including chronic kidney disease, acute kidney injury, bladder illness, and kidney stones, especially in countries like the US, Germany, the UK, China, and India.
The serum creatinine segment is projected to grow rapidly in the global kidney function test market because it shows how well the kidneys are at filtering waste from the blood. It is a crucial marker of kidney health, especially in countries like the US, Germany, the UK, China, and India.
The Asia Pacific kidney function test market is expected to record the maximum market share in revenue in the near future. Because of the large number of government programs showing support and the consistent implementation by healthcare organizations in the region, the test market is expected to be stable over the anticipated time. In addition, Europe is estimated to grow rapidly in the global kidney function test market because of the widespread existence of generic manufacturers and the expanding awareness activities of government and pharmaceutical groups. Rapidly rising investment in research and development by market participants is another factor driving expansion.
| Report Attribute | Specifications |
| Market Size Value In 2022 | USD 863.35 Mn |
| Revenue Forecast In 2031 | USD 1,458.50 Mn |
| Growth Rate CAGR | CAGR of 6.08% from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Mn and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, By Type, By End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Beckman Coulter (US), Siemens (Germany), Nova Biomedical (US), Roche (Switzerland), Abbott (US), URIT Medical (China), ARKRAY (Japan), OPTI Medical (US), ACON Laboratories (US), Sysmex (Japan), 77 Elektronika (Hungary), and Randox Laboratories (UK) |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Kidney Function Test Market By Product-
Kidney Function Test Market By Type
Kidney Function Test Market By End-User
Kidney Function Test Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.